Macrogenics (MGNX) Total Liabilities (2012 - 2026)

Macrogenics (MGNX) has 15 years of Total Liabilities data on file, last reported at $196.7 million in Q1 2026.

• On a quarterly basis, Total Liabilities rose 35.22% year-over-year to $196.7 million in Q1 2026; TTM through Mar 2026 was $196.7 million, a 35.22% increase from a year earlier, with the FY2025 full-year figure at $201.3 million, up 38.23% from the prior year.
• Total Liabilities for Q1 2026 stood at $196.7 million, down from $201.3 million in the prior quarter.
• Over the last five years, Total Liabilities for MGNX reached as high as $234.2 million in Q1 2023 and fell as low as $72.4 million in Q3 2022.
• Historically, Total Liabilities has averaged $150.7 million across 5 years, with a median of $145.4 million in 2025.
• Across the five-year window, Total Liabilities soared 151.24% in 2023 and tumbled 39.32% in 2024, its largest moves.
• Year by year, Total Liabilities stood at $138.5 million in 2022, then advanced by 5.31% to $145.8 million in 2023, then retreated by 0.14% to $145.6 million in 2024, then surged by 38.23% to $201.3 million in 2025, then decreased by 2.28% to $196.7 million in 2026.
• Per Business Quant data, the three most recent Total Liabilities figures were $196.7 million in Q1 2026, $201.3 million in Q4 2025, and $203.8 million in Q3 2025.